With the disease burden of AIDS, tuberculosis, and malaria expected to make up less than 15 percent of the total disease burden in sub-Saharan Africa (SSA) by 2030, and non-communicable diseases to account for nearly 40 percent of the total in the region, “[a] revision of the approach to research and health care in SSA is therefore urgently needed, but international donors and health communities have generally been slow to respond to the changing environment,” Ole Olesen and M. Iqbal Parker of the International Centre for Genetic Engineering and Biotechnology in South Africa write in a commentary in Tropical Medicine & International Health. “Private and public funding for health research in Africa remains therefore disproportionately focused on the three major infectious diseases, whereas only smaller amounts have been allocated to confront other diseases,” they write and provide examples.
Non Communicable Disease/Chronic Disease
IRIN examines the next steps in fighting non-communicable diseases (NCDs), “the leading cause of death worldwide,” noting, “The World Health Assembly, the decision-making body of the U.N. World Health Organization (WHO), aims to reduce preventable deaths from [NCDs] like diabetes, heart attacks and strokes, chronic respiratory diseases and cancers, by 25 percent by 2025.” According to IRIN, “WHO is coordinating negotiations on the surveillance, indicators and voluntary targets that will form an eventual global plan to fight NCDs, and is drafting recommendations to be considered by member governments in October 2012.” IRIN provides a link to a WHO summary of “recent discussions [.pdf] with civil society and government representatives on the best ways to rein in NCDs, and how to measure progress.”
One Blog Examines GAVI Alliance's Efforts To Accelerate Introduction Of Hepatitis B Vaccines In Developing Countries
“I am looking forward to participating in the 2012 World Cancer Leaders’ Summit, to be held in Montreal, Canada on August 27,” GAVI Alliance Deputy CEO Helen Evans writes in this post in the One Blog. “This will be an opportunity to take stock of where the world is with regards to cancer prevention and treatment and to learn more about action to address the existing challenges to eliminating cancer as a life-threatening disease for future generations,” she writes, and discusses GAVI’s efforts to “accelerat[e] the introduction of hepatitis B vaccines in developing countries since 2000,” noting “GAVI has helped prevent an estimated 3.7 million deaths from liver cancer (caused by hepatitis B)” (8/21).
“As world leaders make their way to New York this month to attend the United Nations General Assembly, we call on them to renew their commitments to combating non-communicable diseases (NCDs),” Jill Sheffield, president of Women Deliver, and Nalini Saligram, founder of Arogya World, write in the Huffington Post “Global Motherhood” blog, adding, “Tackling NCDs with a woman-centered focus is a critical step towards reaching all development goals.” They continue, “The solution to curbing NCDs and maternal mortality ultimately rests in improving women’s access to strong and capable health systems.” In addition, “[t]eaching women about NCD prevention by promoting healthy lifestyles will result in women not only changing their own lives, but also steer their families and entire communities towards healthy living,” they state, adding, “Educated and empowered women can work to build a healthier, more sustainable world and lift families out of poverty.” Finally, “[i]t’s also important to look at new solutions and technologies,” including clean cookstoves, Sheffield and Saligram write.
On the one-year anniversary of the U.N. High-Level Meeting on Non-Communicable Diseases (NCDs), two blogs examine what has happened since. In the Center for Global Development’s (CGD) “Global Health Policy” blog, Victoria Fan, a research fellow at the center, and Laura Khan of Princeton University ask, “[W]here has the attention and commitment to NCDs gone?” They say “subsequent attention and action after the NCD Summit last year has been paltry,” and they explore some reasons why this might be the case (9/19). In an interview on the Council on Foreign Relations blog, Thomas Bollyky, senior fellow for global health, economics, and development, says, “So on one hand, the U.N. NCD meeting hasn’t yet managed to follow the HIV/AIDS blueprint in producing a groundswell of popular support, new donor resources, and concrete country action. On the other hand, optimists on this issue believe the U.N. meeting elevated a long-neglected cause to the heads-of-state level and firmly established it as an ongoing concern for the U.N.” (Johnson, 9/19).
Noting this week marks the first anniversary of the U.N. High-Level Meeting on Non-Communicable Diseases (NCDs), a Lancet editorial states, “The meeting was a crucial step for putting diseases such as cancer and cardiovascular disease high on the global health agenda. However, little action, other than more talking, has been taken since.” The editorial continues, “The key positive development of the past year was the goal to reduce preventable deaths from NCDs by 25 percent by 2025 passed by the World Health Assembly in May,” but “[t]he challenge now is how to meet it.”
In this post in the Guardian’s “Poverty Matters” blog, Johanna Ralston, chief executive of the World Heart Federation, and Ann Keeling, chief executive of the International Diabetes Federation, argue non-communicable diseases (NCDs) must be part of any new global development goals, writing, “NCDs and their risk factors worsen poverty, while poverty contributes to rising rates of NCDs, posing a threat to sustainable development.” They continue, “In 2000, world leaders drafting the millennium development goals (MDGs) addressed many of the great development challenges, but they made one serious mistake: they omitted any mention of NCDs, which together cause nearly two out of three deaths in the world (80 percent of those in developing countries).”
New York Mayor Michael Bloomberg on Thursday announced his charitable foundation will “spend $220 million over the next four years to discourage tobacco use in developing countries, as he seeks to promote strategies around the world that curbed smoking in his city,” the Wall Street Journal reports (McKay, 3/21). Bloomberg announced “the new funding for Bloomberg Philanthropies on Thursday at the 15th World Conference on Tobacco or Health in Singapore,” Reuters writes, noting “[t]he commitment takes the foundation’s total pledge to the cause to almost $600 million” (Begley et al., 3/22).
The March issue of the WHO Bulletin features an editorial on global shortages of medicines; a public health round-up; an article on breast cancer awareness; a research paper on interventions for the prevention of mother-to-child HIV transmission in Kwa-Zulu Natal, South Africa; and a paper on the global burden of cholera (March 2012).
This week the WHO brought together lawmakers from across Southeast Asia in Bangkok “to discuss how to bolster their health systems back home,” IRIN reports. Meeting participants were “called on to advocate the boosting of health spending, workforces and access to health care in their home countries in addition to drafting ‘healthy public policies,’ such as conducting health assessments before large infrastructural projects are undertaken,” the news service writes.